Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 5
Submit an article Journal homepage
19
Views
0
CrossRef citations to date
0
Altmetric
Articles

Relationship between acute pancreatitis and ACE inhibitors

Emine TosunTurkish Republic Housing and Development Administration; Ankara, TurkeyCorrespondence[email protected]
,
Berna OksuzoffluAnkara Numune Education and Research Hospital; Ankara, Turkey
&
Oya TopaloffluAnkara Education and Research Hospital, Ankara, Turkey.
Pages 571-572 | Received 10 Nov 2003, Accepted 19 Nov 2003, Published online: 23 May 2017

References

  • Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994: 330: 1198–210.
  • Scarpelli DG. Toxicology of the pancreas. Toxicol Appl Phar-macol 1989; 101: 543–54.
  • Standridge JB. Fulminant pancreatitis associated with lisino-pril therapy. South Med J1994: 87(2): 179–81.
  • Tilkemeier P, Thompson P. Acute pancreatitis possibly related to enalapril (letter). N Engl J Med 1988; 318: 1275–6.
  • Dabaghi S. ACE inhibitors and pancreatitis. Ann Intern Med 1991; 115: 330–1.
  • Maliekal J, Drake CF. Acute pancreatitis with the use of lisinopril. Ann Pharmacother 1993; 27: 1465–6.
  • Bosch X. Losartan-induced acute pancreatitis. Ann Intern Med 1997; 127: 1043–4.
  • Maringhini A, Termini A, Patti R, Ciambra M, Biffarella P. Luigi P. Enalapril-associated acute pancreatitis. Recurrence after rechallenge. Am J Gastroenterol 1997; 92: 166–7.
  • Muchnick JS, Mehta JL. Angiotensin-converting enzyme inhibitor-induced pancreatitis. Gun Cardiol 1999; 22: 50–1.
  • Pickleman J, Straus FH, Poloyan E. Pancreatitis associated with thiazide administration. A role for the parathyroid glands? Arch Surg 1979; 114(9): 1013–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.